Kyle Hoehn

Kyle earned his PhD in Biochemistry from Colorado State University in 2005 where he studied insulin resistance in adipocytes and hibernating marmots with Prof Scott Summers. He then pursued postdoctoral training at the Garvan Institute with Prof David James from 2005-2009 where he studied cell and mouse models of obesity-related insulin resistance. Kyle established his independent lab at the University of Virginia Dept of Pharmacology in 2009 where he began working on small molecule mitochondrial uncoupler drug development. In 2014 he moved his lab to the University of New South Wales where he continues developing mitochondrial uncouplers as therapeutics.